Performance of two questionnaires to measure treatment adherence in patients with Type-2 Diabetes

BMC Public Health

Volumn 9, Issue , 2009, Pages

  Prado Aguilar, Carlos A ^a,b   Martínez, Yolanda V ^a   Segovia Bernal, Yolanda ^a   Reyes Martínez, Rosendo ^a   Arias Ulloa, Raul ^b  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DE AGUASCALIENTES   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT;

AGE; AGED; ARTICLE; ATTITUDE TO HEALTH; COHORT ANALYSIS; COMPARATIVE STUDY; DIABETIC DIET; EVALUATION; FEMALE; FOLLOW UP; HUMAN; LIFESTYLE; MALE; MEXICO; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; PREDICTION AND FORECASTING; QUALITY OF LIFE; QUESTIONNAIRE; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SOCIOECONOMICS; STATISTICAL MODEL; STATISTICS; TREATMENT OUTCOME;

AGE FACTORS; AGED; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC DIET; FEMALE; FOLLOW-UP STUDIES; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; HYPOGLYCEMIC AGENTS; LIFE STYLE; LIKELIHOOD FUNCTIONS; MALE; MEXICO; MIDDLE AGED; PATIENT COMPLIANCE; PREDICTIVE VALUE OF TESTS; QUALITY OF LIFE; QUESTIONNAIRES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEX FACTORS; SOCIOECONOMIC FACTORS; TREATMENT OUTCOME;

EID: 62549156201     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-9-38     Document Type: Article

References (27)

1. Clinical Guideline for Diagnosis and Treatment of Type 2 Diabetes Mellitus. MA Oviedo-Mota F Espinosa-Larrãaga H Reyes-Morales JA Trejo-Perez E Gil-Velazquez, Rev Med Inst Mex Seguro Soc 2003 41 Suppl S27 46
2. Medication adherence and associated hemoglobin A1c in type 2 diabetes. K Krapek K King SS Warren KG George DA Caputo K Mihelich, Ann Pharmacother 2004 38 1357 62 10.1345/aph.1D612 15238621
3. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35). IM Stratton AI Adler HA Neil DR Matthews SE Manley CA Cull, Bmj 2000 321 7258 405 12 10938048 10.1136/bmj.321.7258.405
4. Adherence to medication. L Osterberg T Blaschke, N Engl J Med 2005 353 5 487 97 10.1056/NEJMra050100 16079372
5. Concordance, adherence and compliance in medicine taking. R Horne J Weinman N Barber R Elliot M Morgan, London UK: National Co-ordinating Centre for NHS Service Delivery and Organisation R & D 2005
6. Assessment of sulfonylurea adherence and metabolic control. BJ Mason JR Matsuyama SG Jue, Diabetes Educ 1995 21 1 52 7 10.1177/014572179502100109 7835205
7. Impact of dosage frequency on patient compliance. AH Paes A Bakker CJ Soe-Agnie, Diabetes Care 1997 20 10 1512 7 10.2337/diacare.20.10.1512 9314626
8. A comparison study of multiple measures of adherence to HIV protease inhibitors. H Liu CE Golin LG Miller RD Hays CK Beck S Sanandaji, Ann Intern Med 2001 134 10 968 77 11352698
9. Compliance of pharmacologic prescription in hipertensive patients. C Batalla-Martínez A Blanquer-Laguarta R Ciurana-Misol M García-Soldevilla E Jordi-Cases A Pérez-Calleján, Aten Primaria 1984 1 4 185 91
10. How to diagnose adherence to treatment in primary health care? A Garcia F Leiva F Martos A Garcia D Prados F Sanchez, Medicina de Familia 2000 1 13 9
11. [The validity of 6 indirect methods for assessing drug treatment compliance in arterial hypertension]. F Pineiro V Gil M Donis D Orozco R Pastor J Merino, Aten Primaria 1997 19 7 372 4 6 9254142
12. Concurrent and predictive validity of a self-reported measure of medication adherence. DE Morisky LW Green DM Levine, Med Care 1986 24 1 67 74 10.1097/00005650-198601000-00007 3945130
13. Psychometric Theory. JC Nunnaly, New York: McGraw-Hill 2 1978
14. Adherence to prescribed oral hypoglycaemic medication in a population of patients with Type 2 diabetes: a retrospective cohort study. PT Donnan TM MacDonald AD Morris, Diabet Med 2002 19 4 279 84 10.1046/j.1464-5491.2002.00689. x 11942998
15. Clinical Epidemiology: a Basic Science for Clinical Medicine. DL Sackett RB Haynes GH Guyatt P Tugwell, Boston: Little, Brown and Company 2 1991
16. PAHO, Epidat 3.1 Washington D.C: Pan American Health Organization 2005
17. Sample size calculations in studies of test accuracy. NA Obuchowski, Stat Methods Med Res 1998 7 4 371 92 10.1191/096228098678080061 9871953
18. Clinical Epidemiology. The Essentials. RH Fletcher SW Fletcher EH Wagner, Maryland, USA: Williams & Wilkins 1996
19. SPSSInc, SPSS version 11.0.0 for Windows Chicago SPSS Inc 2001
20. F Schoonjans, MedCalc Software. Version 10.0.1.0 ed. Broekstraat 52, 9030 Mariakerke, Belgium 2008
21. Compliance: the dilemma of the chronically ill. K Gerber A Nehemkis, New York: Springer Publishing Company, Inc 1986
22. Monitoring adherence to prescribed medication in type 2 diabetic patients treated with sulfonylureas. A Winkler AU Teuscher B Mueller P Diem, Swiss Med Wkly 2002 132 27-28 379 85 12428192
23. A systematic review of the associations between dose regimens and medication compliance. AJ Claxton J Cramer C Pierce, Clin Ther 2001 23 8 1296 310 10.1016/S0149-2918(01)80109-0 11558866
24. [Pharmacological therapy compliance in diabetes]. BR Duran-Varela B Rivera-Chavira E Franco-Gallegos, Salud Publica Mex 2001 43 3 233 6 11452700
25. Can simple clinical measurements detect patient noncompliance? RB Haynes DW Taylor DL Sackett ES Gibson CD Bernholz J Mukherjee, Hypertension 1980 2 6 757 64 7007235
26. INEGI, Encuesta Nacional sobre Disponibilidad y Uso de las Tecnologías de la Informacián en los Hogares Mexico: INEGI 2008
27. Relationship of functional health literacy to patients' knowledge of their chronic disease. A study of patients with hypertension and diabetes. MV Williams DW Baker RM Parker JR Nurss, Archives of internal medicine 1998 158 2 166 72 10.1001/archinte.158.2.166 9448555